RVX_logo_RGB.jpg
Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement
08 janv. 2018 08h57 HE | Resverlogix Corp
CALGARY, Alberta, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that it has entered into a licensing agreement with Medison...